Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

Rethinking trials: the pros and cons of protocol amendments

Rethinking trials: the pros and cons of protocol amendments

A protocol change can work wonders – just ask AstraZeneca. In August, AstraZeneca’s systemic lupus erythematosus candidate anifrolumab achieved the primary efficacy endpoint in an amended trial called Tulip-2. ... AstraZeneca’s motivation for

Novartis changes focus in Shanghai from early research to drug development

Novartis changes focus in Shanghai from early research to drug development Among other big Western pharma players focusing on China as a source of growth potential is AstraZeneca, which recently launched a $1bn investment fund for Chinese healthcare and biotech start-ups. ... AstraZeneca also has two new R&D facilities in

Bayer, Merck’s high-risk heart failure drug comes good in phase 3

Bayer, Merck’s high-risk heart failure drug comes good in phase 3 Another question for vericiguat is how it will stack up against SGLT2 inhibitors such as Boehringer Ingelheim/Eli Lilly’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin).

BeiGene bags FDA approval for first product Brukinsa in lymphoma

BeiGene bags FDA approval for first product Brukinsa in lymphoma First-to-market Imbruvica made more than $4bn in sales in the US market alone last year and remains the clear market leader despite some encroachment from AstraZeneca’s Calquence (acalabrutinib).

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post The company then suffered another major blow earlier this year when poor late-stage trial results for an antidepressant candidate abruptly brought about the end of its collaboration with AstraZeneca. .

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma...
WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....

Infographics